Table 3. Multiple logistic regression analysis of factors associated with significant fibrosis in HBeAg (−) patients.
| Parameter | Not significant | Significant | P | Multivariate | |||
|---|---|---|---|---|---|---|---|
| OR | 95% CI | Wald | P | ||||
| Age, years | 33.56 ± 12.73 | 42.11 ± 12.22 | < 0.001 | 1.04 | 1.00–1.08 | 3.53 | 0.060 |
| PLT, 109/L | 199.66 ± 52.90 | 146.94 ± 61.81 | < 0.001 | 0.99 | 0.98–1.00 | 11.00 | 0.001 |
| ALT, U/L | 112.68 ± 253.23 | 190.89 ± 209.30 | 0.064 | 1.00 | 1.00–1.00 | 0.60 | 0.441 |
| AST, U/L | 60.95 ± 114.17 | 115.44 ± 146.46 | 0.036 | 1.01 | 1.00–1.02 | 2.30 | 0.129 |
| TBIL, μmol/L | 19.85 ± 19.52 | 23.67 ± 19.56 | 0.298 | 0.99 | 0.94–1.04 | 0.23 | 0.633 |
| HBV DNA, log10IU/mL | 4.51 ± 1.52 | 5.20 ± 1.30 | 0.008 | 1.32 | 0.94–1.85 | 2.64 | 0.104 |
| HBsAg, log10IU/mL | 3.54 ± 0.67 | 3.43 ± 0.53 | 0.308 | 1.04 | 0.48–2.26 | 0.01 | 0.926 |
| qAnti-HBc, log10IU/mL | 4.19 ± 0.64 | 4.67 ± 0.53 | < 0.001 | 3.36 | 1.33–8.47 | 6.59 | 0.010 |